Follow
Jittasak (Jake) Khowsathit
Jittasak (Jake) Khowsathit
Postdoctoral Associate, Fox Chase Cancer Center
Verified email at fccc.edu
Title
Cited by
Cited by
Year
Targeting CDK9 reactivates epigenetically silenced genes in cancer
H Zhang, S Pandey, M Travers, H Sun, G Morton, J Madzo, W Chung, ...
Cell 175 (5), 1244-1258. e26, 2018
2002018
Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase
CE Keohane, AD Steele, C Fetzer, J Khowsathit, D Van Tyne, L Moynié, ...
Journal of the American Chemical Society 140 (5), 1774-1782, 2018
712018
DARC: mapping surface topography by ray-casting for effective virtual screening at protein interaction sites
R Gowthaman, SA Miller, S Rogers, J Khowsathit, L Lan, N Bai, ...
Journal of medicinal chemistry 59 (9), 4152-4170, 2016
252016
Target-based design of promysalin analogues identifies a new putative binding cleft in succinate dehydrogenase
SJ Post, CE Keohane, LM Rossiter, AR Kaplan, J Khowsathit, K Matuska, ...
ACS infectious diseases 6 (6), 1372-1377, 2020
122020
Computational design of an allosteric antibody switch by deletion and rescue of a complex structural constellation
J Khowsathit, A Bazzoli, H Cheng, J Karanicolas
ACS Central Science 6 (3), 390-403, 2020
92020
Modulating antibody structure and function through directed mutations and chemical rescue
CE Kaiser, JP Rincon Pabon, J Khowsathit, MP Castaldi, SL Kazmirski, ...
ACS synthetic biology 7 (4), 1152-1162, 2018
72018
Correction to “Target-Based Design of Promysalin Analogs Identifies a New Putative Binding Cleft in Succinate Dehydrogenase”
SJ Post, CE Keohane, LM Rossiter, AR Kaplan, J Khowsathit, K Matuska, ...
ACS Infectious Diseases 8 (7), 1376-1376, 2022
12022
Target-Based Design of Promysalin Analogs Identifies a New Putative Binding Cleft in Succinate Dehydrogenase (vol 6, pg 1372, 2020)
SJ Post, CE Keohane, LM Rossiter, AR Kaplan, J Khowsathit, K Matuska, ...
ACS INFECTIOUS DISEASES 8 (7), 2022
2022
Compositions and methods for modulation of antibody activity
J Karanicolas, J Khowsathit, DP Yeggoni
US Patent App. 17/600,831, 2022
2022
Using Chemical Biology to Modulate Antibody Activity
J Khowsathit
University of Kansas, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–10